ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Integrated BioPharma Inc (QX)

Integrated BioPharma Inc (QX) (INBP)

0.20
0.00
(0.00%)
Closed July 23 4:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.20
Bid
0.173
Ask
0.20
Volume
1,000
0.20 Day's Range 0.20
0.17 52 Week Range 0.3349
Market Cap
Previous Close
0.20
Open
0.20
Last Trade
1000
@
0.2
Last Trade Time
Financial Volume
$ 200
VWAP
0.20
Average Volume (3m)
2,422
Shares Outstanding
30,099,610
Dividend Yield
-
PE Ratio
-181.82
Earnings Per Share (EPS)
-0
Revenue
50.67M
Net Profit
-34k

About Integrated BioPharma Inc (QX)

Integrated BioPharma, Inc., a Delaware corporation (together with its subsidiaries, the "Company"), is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company does business as Chem International, Inc. with certain of... Integrated BioPharma, Inc., a Delaware corporation (together with its subsidiaries, the "Company"), is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company does business as Chem International, Inc. with certain of its customers and certain vendors. The Company's business segments include: (a) Contract Manufacturing operated by InB:Manhattan Drug Company, Inc. ("MDC"), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; (b) Branded Proprietary Products operated by AgroLabs, Inc. ("AgroLabs"), which distributes healthful nutritional products for sale through major mass market, grocery, drug and vitamin retailers, and (c) Other Nutraceutical Businesses which includes the operations of (i) The Vitamin Factory which sells private label MDC products, as well as our AgroLabs products, through the Internet, (ii) IHT Health Products, Inc. ("IHT") a distributor of fine natural botanicals, including multi minerals produced under a license agreement, (iii) MDC Warehousing and Distribution, Inc., a service provider for warehousing and fulfilment services and (iv) Chem International, Inc., a distributor of certain raw materials for DSM Nutritional Products LLC. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Integrated BioPharma Inc (QX) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker INBP. The last closing price for Integrated BioPharma (QX) was $0.20. Over the last year, Integrated BioPharma (QX) shares have traded in a share price range of $ 0.17 to $ 0.3349.

Integrated BioPharma (QX) currently has 30,099,610 shares outstanding. The market capitalization of Integrated BioPharma (QX) is $6.02 million. Integrated BioPharma (QX) has a price to earnings ratio (PE ratio) of -181.82.

INBP Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000.2000CS
4-0.01-4.76190476190.210.210.17517730.20056402CS
120.019410.74197120710.18060.250.17324220.20507768CS
26-0.0335-14.34689507490.23350.250.17360670.21301449CS
52-0.09457-32.10442339680.294570.33490.1791380.23954131CS
156-0.81-80.1980198021.011.180.17105250.69559431CS
260-0.05-200.251.250.17121790.70039257CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUZENuZee Inc
$ 2.02
(96.12%)
2.47M
ALLRAllarity Therapeutics Inc
$ 0.2503
(50.33%)
43M
NIVFNewGenIvf Group Ltd
$ 1.29
(48.12%)
4.8M
DRMADermata Therapeutics Inc
$ 1.56
(20.00%)
116.64k
SLNASelina Hospitality PLC
$ 0.0304
(16.92%)
48.74M
VSTMVerastem Inc
$ 2.66
(-25.91%)
461.9k
IONMAssure Holdings Corporation
$ 1.8599
(-23.46%)
67.05k
CJETChijet Motor Company Inc
$ 4.20
(-17.32%)
92.01k
ALPPAlpine 4 Holdings Inc
$ 0.499
(-16.82%)
307.06k
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 11.4099
(-16.72%)
18.5M
SLNASelina Hospitality PLC
$ 0.0304
(16.92%)
48.74M
ALLRAllarity Therapeutics Inc
$ 0.2503
(50.33%)
43M
TSLATesla Inc
$ 225.64
(-8.42%)
19.73M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 11.4099
(-16.72%)
18.5M
HOLOMicroCloud Hologram Inc
$ 0.5801
(-0.80%)
9.9M

INBP Discussion

View Posts
greasemonkeyshoes greasemonkeyshoes 4 years ago
Added few more shares.....
this baby is on fire and chieeeeppppppppppppppp!
πŸ‘οΈ0
bobkubecka bobkubecka 4 years ago
INBP 10k filed
https://www.otcmarkets.com/filing/html?id=13912523&guid=lQACUKuJUTjIW3h
πŸ‘οΈ0
Golden Cross Golden Cross 5 years ago
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2019
Press Release | 11/13/2019
HILLSIDE, NJ / ACCESSWIRE / November 13, 2019 / Integrated BioPharma, Inc. (OTC BB:INBP) (the "Company") reports it financial results for the quarter ended September 30, 2019.

Revenue for the quarter ended September 30, 2019 was $11.4 million compared to $10.3 million for the quarter ended September 30, 2018, an increase of $1.1 million or 10.7%. The Company had operating income for the quarter ended September 30, 2019 of $0.5 million compared to operating income of $0.4 million for the quarter ended September 30, 2018.

For the quarter ended September 30, 2019, the Company had net income and diluted net income of $0.3 million or $0.01 per share of common stock, compared with net income and diluted net income of $0.2 million or $0.01 per share of common stock for the quarter ended September 30, 2018.

"We are excited to report that our revenue increased by approximately 11% in the quarter ended September 30, 2019 and that our revenue from our two significant customers in our Contract Manufacturing Segment remained consistent; representing approximately 91% and 89% of total revenue in the quarters ended September 30, 2019 and 2018, respectively," said Riva Sheppard, Co-Chief Executive Officer of the Company.

A summary of our financial results for the three months ended September 30, 2019 follows:

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share amounts)
(unaudited)
Three Months Ended
September 30,
2019 2018
Total revenue
$ 11,406 $ 10,304
Cost of sales
10,007 9,085
Gross profit
1,399 1,219
Selling and administrative expenses
923 814
Operating income
476 405
Other expense, net (1)
(127 ) (191 )
Income before income taxes
349 214
Income tax expense, net
37 55
Net income
$ 312 $ 159
Net income per common share:
Basic
$ 0.01 $ 0.01
Diluted
$ 0.01 $ 0.01
Weighted average common shares outstanding:
Basic
29,565,943 27,218,786
Diluted
30,724,633 27,963,604
(1) Includes interest expense of $124 and $200, respectively.
SOURCE: Integrated BioPharma, Inc.



View source version on accesswire.com:
https://www.accesswire.com/566451/Integrated-BioPharma-Reports-Results-for-its-Quarter-Ended-September-30-2019
πŸ‘οΈ0
bobkubecka bobkubecka 5 years ago
INBP 10k filed
https://www.otcmarkets.com/filing/html?id=13618471&guid=-U6IUe4whcTGP3h
πŸ‘οΈ0
bonedaddy77 bonedaddy77 5 years ago
I'm surprised there isn't more love here. I saw Q3 financials and they look pretty good.
πŸ‘οΈ0
greasemonkeyshoes greasemonkeyshoes 5 years ago
eps=3c.....
or 12c x 5(pe) = 60c stock in the making.wooowwwww.
πŸ‘οΈ0
greasemonkeyshoes greasemonkeyshoes 5 years ago
Not bad....
Revenue up 11%
eps .008c or 3.2c annualized
inventory is up $2.0 million,must expect $12+ million shipment next few quarters.
πŸ‘οΈ0
greasemonkeyshoes greasemonkeyshoes 5 years ago
Yes,for q2 which ended on 12/31/18......
ER due out most likely today.This company has many moving parts,I hope $500k operating income stays up,generating enough cash and lower their debt level due in 2020.Once inbp got its act together,top line of $10+ million/q can do a lot of damage(in a positive way).
πŸ‘οΈ0
Knowledge is King Knowledge is King 5 years ago
Is this a prediction for the 12/18 Q?
πŸ‘οΈ0
greasemonkeyshoes greasemonkeyshoes 5 years ago
This ER numbers........
rev 11.4 million
cost 10.0 million(88%)
sg&a 0.85 million(7%)
net income 0.28 million(2%) or 1c
forward pe@13c:
13c/1c*4=3.3
πŸ‘οΈ0
greasemonkeyshoes greasemonkeyshoes 6 years ago
Buy.....
q4(6/30/18):
revenue up 12%
net income $818k w/change of derivative&others $461k(benefit).
or
this dog is getting rid of its flee,1 or 2 more q to go,before complete eradication.Wooowwwww.
πŸ‘οΈ0
greasemonkeyshoes greasemonkeyshoes 6 years ago
10Q pending.......
This dog with flee is on the move.A good q coming??
πŸ‘οΈ0
greasemonkeyshoes greasemonkeyshoes 6 years ago
$5.3 million of convertible debt to equity @65c........
With current quote of the stock at 16c,the greatest thing since the sliced of bread just occured,a gift to the shareholders/company.Nothing can be better than this event.Wooowwwwww.
Bottom line to the capital structure:
$4.0 million net debt reduction,at no dilution to its shareholders.
Saving of $318k of interest expense annually.
πŸ‘οΈ0
aetosellinas aetosellinas 10 years ago
What a week INBP & IBIO
I smell some HUGE gains here folks
πŸ‘οΈ0
DChow DChow 10 years ago
Shhhhhhhhhhhhhhhhhhh
πŸ‘οΈ0
aetosellinas aetosellinas 10 years ago
Oh they will :), very interesting week coming. Given how low the float is here, we may see some crazy runs here
πŸ‘οΈ0
balamidas balamidas 10 years ago
...



πŸ‘οΈ0
©PROPHETABLE ©PROPHETABLE 10 years ago
***MARK IT***


NEXT EBOLA RUNNER...

IF YOU'RE NOT LOADING, WE ARE...TIC...TOC...TIC...TOC...TIC...TOC...
πŸ‘οΈ0
TradeSmart.ai TradeSmart.ai 10 years ago
Surprised more people haven't caught on to this yet ;]

$INBP
πŸ‘οΈ0
aetosellinas aetosellinas 10 years ago
INBP-our hidden under the radar gem holding about 1.7 million shares of IBIO woweeee lol. This is going to get very interesting, with less the a million float who knows how high this can reach here. It's IBIO investment alone is about 5.5 million, what's to stop IBIO from surging up much more ahead if it's recent developments.
Things are going to get very interesting, too bad we're so under the radar, I'm sure that'll change :)
πŸ‘οΈ0
aetosellinas aetosellinas 10 years ago
Monster is an understatement, market cap is so low and discounted and the float here is only like 1 million
It's crazy to see still at these levels, people haven't the slightest idea
πŸ‘οΈ0
angelo2112 angelo2112 10 years ago
People starting to put 2&2 together I see... Nice!
This will be a monster runner mark it!
πŸ‘οΈ0
tommie0908 tommie0908 10 years ago
Got me a starter position today
πŸ‘οΈ0
GOLDMAN STACKS GOLDMAN STACKS 10 years ago
Boom!!!!
πŸ‘οΈ0
©PROPHETABLE ©PROPHETABLE 10 years ago
Me likey!!!
πŸ‘οΈ0
Talc Moan Talc Moan 10 years ago
I thought you knew for some reason lol!
πŸ‘οΈ0
MONEYMADE MONEYMADE 10 years ago
NOW YA TELL ME!!! HAHAA NICE FIND
πŸ‘οΈ0
Talc Moan Talc Moan 10 years ago
INBP valuation is going through the roof. 21 mill OS and 70% owned by insiders. They own 1.2 million shares of IBIO now valued at almost 3 million dollars.

The share price will keep rising with Ibio's advancement.
πŸ‘οΈ0
Sibware Sibware 10 years ago
Well.Houston.We have an INdescriBable Problem==>

I AM your wife.

Been following you since a while, without you knowing it...

Ebola Fever??? Huh!!!!

I'm gonna show you what a fever feels like, tonight!!!



Can you hear me???

πŸ‘οΈ0
CDBLEG CDBLEG 10 years ago
Whats your opinion on this chart here? Been following it and trying to see where this is going. Newbie here
πŸ‘οΈ0
Talc Moan Talc Moan 10 years ago
LOL... Tell my wife that plzzzzzz
πŸ‘οΈ0
Sibware Sibware 10 years ago
LMAO! At least, he's good at something...
πŸ‘οΈ0
Talc Moan Talc Moan 10 years ago
Nah just a pumper "LOL"
πŸ‘οΈ0
Sibware Sibware 10 years ago
You know him too??? They say he's very good...
πŸ‘οΈ0
Talc Moan Talc Moan 10 years ago
Lmao!
πŸ‘οΈ0
Sibware Sibware 10 years ago
Heard_they_have_an advisor named smitter or something like that...Lol...
πŸ‘οΈ0
Talc Moan Talc Moan 10 years ago
Make you go hmmmmmmmmmmm
πŸ‘οΈ0
Talc Moan Talc Moan 10 years ago
Yep, and they prob have some insider knowledge of what is going on over at IBIO.
πŸ‘οΈ0
Sibware Sibware 10 years ago
I'm sure they know when's the best time to sell some of their IBIO shares...

What will be interesting also is, what will they do with all that money>>>>

πŸ‘οΈ0
Talc Moan Talc Moan 10 years ago
They own 1.2 mill IBIO. They better hold it. IBIO gonna be $10+ prob less than a few weeks. This company is going to be cash heavy!
πŸ‘οΈ0
Sibware Sibware 10 years ago
INBP: Cash coming in... ***
πŸ‘οΈ0
Talc Moan Talc Moan 10 years ago
The higher IBIO goes the more Value this gets and exposure.
πŸ‘οΈ0
aetosellinas aetosellinas 10 years ago
.30 next .38-.42
πŸ‘οΈ0
Talc Moan Talc Moan 10 years ago
.28+++
πŸ‘οΈ0
aetosellinas aetosellinas 10 years ago
Here we go, watch volume this moves like crazy could see .50 today plus
πŸ‘οΈ0
aetosellinas aetosellinas 10 years ago
Pop to 30's-45+++
Be ready
πŸ‘οΈ0
Talc Moan Talc Moan 10 years ago
.22
πŸ‘οΈ0
Talc Moan Talc Moan 10 years ago
Investment in iBio, Inc. The Company accounts for its investment in iBio, Inc. (β€œiBio”) common stock on the cost basis as it retained approximately 6% of its interest in iBio (1,266,706 common shares) (the β€œiBio Stock”) at the time of the spin-off of this subsidiary in August 2008. The Company reviews its investment in iBio for impairment and records a loss when there is deemed to be an impairment of the investment. There were impairment charges of $152 and $139 recorded in the fiscal years ended June 30, 2014 and 2013, respectively. The market value of the iBio Stock as of June 30, 2014, was approximately $0.5 million. Pursuant to the Company’s Loan Agreement with PNC Bank, National Association (β€œPNC”), the Company is required to sell the iBio Stock when the trading price of the iBio Stock is less than $0.88 per share for a period of fifteen (15) consecutive trading days on the applicable exchange and utilize all proceeds from such sale to prepay the outstanding principal of the term loan outstanding under the Loan Agreement at such time. In the fiscal years ended June 30, 2014 and 2013, the trading price of the iBio Stock was less than $0.88 for a period of fifteen (15) consecutive trading days. (See Note 6. Senior Credit Facility, Subordinated Convertible Note Payable, net - CD Financial, LLC and other Long Term Debt). As of September 8, 2014, the Company has not sold any shares of the iBio Stock.




Looks like they are gonna be CASH HEAVY soon LOL!
πŸ‘οΈ0
willlbone willlbone 10 years ago
Very small float.
πŸ‘οΈ0
DUKES BOY DUKES BOY 10 years ago
Scramracing I'm in Pphm left this thing in 2012
πŸ‘οΈ0